Aproaches to immunotherapy in different immunophenotypes of cutaneous basal cell carcinoma

Voprosy Onkologii

Volumn 58, Issue 3, 2012, Pages 406-415

  Petrunin, D D ^a   Okovityi, S V ^b   Kostalevskaya, A V ^c   Suchkov, S V ^d  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b ST PETERSBURG STATE CHEMICAL PHARMACEUTICAL ACADEMY   (Russian Federation)

^c Department of Health   (Russian Federation)

^d I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALBINTERFERON ALPHA2B; CYCLOFERON; GENFERON; IMMUNOMODULATING AGENT; UNCLASSIFIED DRUG; 10-CARBOXYMETHYL-9-ACRIDANONE; ACRIDINE DERIVATIVE; ALPHA INTERFERON; CRIDANIMOD; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON INDUCING AGENT;

ARTICLE; BASAL CELL CARCINOMA; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; RECURRENCE RISK; ADULT; AGED; BLOOD; DRUG ADMINISTRATION; FEMALE; IMMUNOLOGY; IMMUNOTHERAPY; INJECTION; MALE; METHODOLOGY; MIDDLE AGED; SKIN TUMOR; SUPPOSITORY; TREATMENT OUTCOME;

ACRIDINES; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; IMMUNOTHERAPY; INJECTIONS; INTERFERON INDUCERS; INTERFERON-ALPHA; MALE; MIDDLE AGED; SKIN NEOPLASMS; SUPPOSITORIES; TREATMENT OUTCOME;

EID: 84865856595     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cornell R. C., Greenway H. T., Tucker S. B., Edwards L. et al. Intralesional interferon therapy for basal cell carcinoma // J. Amer. Acad. Dermatol. - 1990. - Vol. 23. -P. 694-700.
2. De Clercq E. Interferon and its inducers - a never-ending story: «old» and «new» data in a new perspective // J. Infect Dis. - 2006. - Vol. 194 (Suppl. 1). - P. S19-26.
3. Dubin N., Kopf A. W. Multivariate risk score for recurrence of cutaneous basal cell carcinomas // Arch Dermatol. - 1983. - Vol. 119. - P. 373-377.
4. Edwards L., Whiting D., Rogers D. et al. The effect of intralesional interferon gamma on basal cell carcinomas // J. Amer. Acad. Dermatol. - 1990. - Vol. 22. - P. 496-500.
5. Foster G. R., Rodrigues O., Ghouze F. et al. Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency // J. Int. Cytokine Res. - 1996. - Vol. 16. - P. 1027-1033.
6. Ikić D., Padovan I., Pipić N. et al. Basal cell carcinoma treated with interferon // Int. J. Dermatol. - 1991. -Vol. 30. - P. 734-737.
7. Lippman S. M., Shimm D. S., Meyskens F. L. Jr. Non-surgical treatments for skin cancer: retinoids and alfa-interferon // J. Dermatol. Surg. Oncol. - 1988. - Vol. 14. -P. 862-869.
8. Marks R., Jolley D., Dorevitch A., Selwood T. The incidence of non-melanocytic skin cancers in an Australian population: results of a five year prospective study // Med. J. - 1989. - Vol. 150. - P. 475-478.
9. Preston D. S., Stern R. S. Non-melanoma cancer of the skin // New Eng. J. Med. 1992. - Vo1. 327. - P. 1649-1662.
10. Serrano H., Scotto J., Shornick G. et al. Incidence of non-melanoma skin cancer in New Hampshire and Vermont // J. Amer. Acad. Dermatol. - 1991. - Vol. 24. - P. 574-579.
11. Smith S. P., Grande D. J. Basal cell carcinoma recurring after radiotherapy: a unique difficult treatment subclass of recurrent basal cell carcinoma // J. Dermatol. Surg. Oncol. - 1991. - Vol. 17. - P. 26-30.
12. Suchkov S. V., Petrunin D. D., Kostalevskaya A. V. et al. Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation // Biomed. pharmacother. - 2007. - Vol. 61. - P. 323-337.
13. Tank B., Habets J. M., Naafs B. et al. Intralesional treatment of basal cell carcinoma with low-dose recombinant interferon gamma // J. Amer. Acad. Dermatol. - 1989. -Vol. 21. - P. 734-735.
14. Wickramasinghe L., Hindson T. C., Wacks H. Treatment of neoplastic skin lesions with intralesional interferon // J. Amer. Acad. Dermatol. - 1989. - Vol. 20. - P. 71-74.